22
Views
5
CrossRef citations to date
0
Altmetric
CASE REPORT

Infectious mononucleosis-like syndrome induced by salazosulfapyridine in a patient with rheumatoid arthritis

, , &
Pages 492-495 | Received 13 Mar 2007, Accepted 04 Jun 2007, Published online: 02 Jan 2014

References

  • Tohyama M, Hashimoto K. Drug-induced hypersensitivity syn-drome and HHV-6. Clin Immunol 2003;40:219–21.
  • Kunisaki Y, Goto H, Kitagawa K, Nagano M. Salazosulfapyridine-induced hypersensitivity syndrome associated with reactivation of human herpes virus 6. Intern Med 2003;42:203–7.
  • Tohyama M, Hashimoto K. Hypersensitivity syndrome. Clin Dermatol 1999;53:45–9.
  • Vittorio CC, Muglia JJ. Anticonvulsant hypersensitivity syndrome. Arch Intern Med 1995;155:2285–90.
  • Hara H, Tanabe K, Doi M, Eto H, Sugita A, Komatu T, et al. Salazosulfapyridine-induced drug eruption mimicking infectious mononucleosis (in Japanese). Ftinsho Derma 1998;40:77–81.
  • Ito Y, Asano K, Matsuo S, Naruse H, Ezuka H. A case of drug eruption due to salazosulfapyridine mimicking infectious mono-nucleosis (in Japanese). Ftinsho Derma 1996;38:1057–60.
  • Futei Y, Taguchi H, Konohana I. Two cases of drug eruption due to salazosulfapyridine, showing infectious mononucleosis-like symp-toms. Chin Dermatol 2000;54:147–9.
  • Hakuno M, Kikuchi S, Ide E, Matsuyama H, Ikeda Y, Nishikawa T, et al. A case of drug eruption due to salazosulfapyridine mimicking infectious mononucleosis (in Japanese). Ftinsho Derma 1994;36: 1219–23.
  • Klotz U. Clinical pharmacokinetics of sulphasalazine, its metabo-lites and other prodrugs of 5-aminosalicylic acid. Clin Pharmaco-kinet 1985;10:285–302.
  • Ohtani T, Hiroi A, Sakurane M, Furukawa F. Slow acetylator geno-types as a possible risk factor for infectious mononucleosis-like syndrome induced by salazosulfapyridine. Br J Dermatol 2003; 148:1035–9.
  • Matsuo S, Nakayama H, Imai T. Two cases of severe drug eruption due to salazopyrine, associated with ulcerative-colitis. Chin Derma-tol 1981;35:1135–43.
  • Iwatsuki K, Tsugiki M, Tagami H, Yamada M. Infectious mononucleosis-like manifestations. Arch Dermatol 1984;120: 964–5.
  • Yamaguchi F. Drug eruption due to salazosulfapyridine (in Japanese). Nihon Hifuka Gakkai Zasshi 1986;96 Supp1:58.
  • Toriyama F, A case of severe drug eruption due to salazopyrine with unique lymphadenopathy (in Japanese). Nishinihon Hifuka Gakkai Zasshi 1992;54 Supp1:823.
  • Tamaki A, Yamamoto M. A case of drug eruption due to salazosul-fapyridine (in Japanese). Ftinsho Derma 1992;34:479–82.
  • Tohyama M,Yahata Y,Yasukawa M, Urano Y, Yamanishi K, Hashi-moto K. Severe hypersensitivity syndrome due to sulfasalazine associated with reactivation of human herpes virus 6. Arch Derma-tol 1998;134:1113–7.
  • Chen M, Xia B, Chen B, Guo Q, Li J, Ye M, et al. N-acetyltransfer-ase 2 slow acetylator genotype associated with adverse effects of sulphasalazine in the treatment of inflammatory bowel disease. Can J Gastroenterol 2007;21:155–8.
  • Laversuch CJ, Collins DA, Charles PJ, Bourke BE. Sulphasalazine-induced autoimmune abnormalities in patients with rheumatic diseases. Br J Ftheumatol 1995;34:435–9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.